The Asia Pacific Breast Retractors Market would witness market growth of 5.6% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 399.5 thousand units, showcasing a growth of 5.5% (2019-2022).
The rising incidence of breast cancer regionally, especially in industrialized areas, and its high mortality rate, especially in developing countries, are significant factors fueling the demand for breast surgery. Thus, the need for improved surgical instruments, including breast surgery retractors, is driven by this. As less invasive procedures for breast cosmetic surgery become more popular, there is an increasing demand for breast surgery retractor devices. As a result of women's increased knowledge of the hazards associated with breast cancer, a considerable increase in the number of surgeries such as mastectomy and lumpectomy has been seen. Many women who undergo mastectomy procedures for breast cancer opt for breast reconstruction to restore their breast's appearance. Breast retractors are crucial in mastectomy and reconstructive surgeries, contributing to the increased demand.
The rising demand for breast retractors results from the success and effectiveness of plastic surgery procedures, including breast reduction and reconstruction, enhancing the market. Women adopt such surgeries to increase breast size for reconstruction purposes after mastectomy, which is anticipated to drive market growth in the near future.
Clinics in China are vital in providing breast-related healthcare services, from diagnostics and consultations to minimally invasive procedures and cosmetic surgeries. They contribute to the demand for breast retractors by ensuring patients receive precise and safe care, whether for medical treatment or aesthetic enhancement. There is a growing demand for breast reduction surgery in China, driven by improved awareness of breast health, changing beauty standards, and an emphasis on patient-centered care. Breast reduction surgery has significantly driven the demand for specialized breast retractors in China. The procedure's emphasis on patient-centered care, minimal scarring, and improved cosmetic outcomes has led to the development and adoption of advanced breast retractors, essential for successful breast reduction surgeries. By 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Moreover, as per the National Library of Medicine, in China, breast cancer was the fifth leading cause of cancer-related fatalities among women in 2015.
According to ISAPS 2022, the total number of breast surgeries in the Japan was 15,476. This included the numbers for breast augmentation, breast implant removal, breast lift, breast reduction, and gynecomastia, which were 8,238, 2,790, 260, 4,108, and 80 respectively. All these factors will uplift the regional market expansion in the coming years.
The China market dominated the Asia Pacific Breast Retractors Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $33,000.2 Thousands by 2030. The Japan market is registering a CAGR of 5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.3% during (2023 - 2030).
Based on Type, the market is segmented into Handheld, and Self-retaining. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Clinics. Based on Usage, the market is segmented into Reusable, and Disposable. Based on Application, the market is segmented into Breast Augmentation, Breast Reconstruction, Mastectomy, Breast Reduction, and Lumpectomy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Breast Retractors Market is Predict to reach $473.6 Million by 2030, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Integra LifeSciences Holdings Corporation, OBP Medical Corporation, Gulmaher Surgico, Jalal Surgical, Hayden Medical Inc., Thompson Surgical Instruments Inc., CooperSurgical, Inc. (The Cooper Companies, Inc.), and Surtex Instruments Ltd.
By Type (Volume, Thousand Units, USD Thousands, 2019-2030)
By End-use (Volume, Thousand Units, USD Thousands, 2019-2030)
By Usage (Volume, Thousand Units, USD Thousands, 2019-2030)
By Application (Volume, Thousand Units, USD Thousands, 2019-2030)
By Country (Volume, Thousand Units, USD Thousands, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 